These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 3274451)

  • 21. Effect of HLA matching and T- and B-cell crossmatch on acute rejection and graft survival following liver transplantation.
    Chen M; Wade J; Levy GA; Greig PD
    Transplant Proc; 1994 Oct; 26(5):2695-6. PubMed ID: 7940844
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical relevance of a positive B-cell crossmatch on renal transplantation: a multi-transplant center evaluation.
    Bryan CF; Aeder MI; Helling TS; Luger AM; Nelson PW; Pierce GE
    Transplant Proc; 1993 Feb; 25(1 Pt 1):247-50. PubMed ID: 8438288
    [No Abstract]   [Full Text] [Related]  

  • 23. Early graft function in primary and regraft recipients of paired cadaveric kidneys.
    Jaklitsch MT; Deierhoi MH; Hudson S; Barber WH; Barger BO; Phillips MG; Diethelm AG
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1274-5. PubMed ID: 2652421
    [No Abstract]   [Full Text] [Related]  

  • 24. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
    Light JA; Aquino A; Ali A; Rodriguez R; Ali S
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897
    [No Abstract]   [Full Text] [Related]  

  • 25. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
    Gianello P; Squifflet JP; Pirson Y; Stoffel M; Dereme T; Alexandre GP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
    [No Abstract]   [Full Text] [Related]  

  • 26. Contribution of T-cell subset monitoring of renal transplant recipients in the cyclosporine era.
    Khanuja PS; Toledo-Pereyra LH; Gordon DA; Bandlien KO; Whitten JI
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1852-3. PubMed ID: 2652602
    [No Abstract]   [Full Text] [Related]  

  • 27. Differential crossmatch in renal transplantation: allopositive historical crossmatch (B and/or T) but current T-cell negative crossmatch.
    Guerin C; Pomier G; Fleuru H; Laverne S; Le Petit JC; Berthoux FC
    Transplant Proc; 1990 Oct; 22(5):2286. PubMed ID: 2219371
    [No Abstract]   [Full Text] [Related]  

  • 28. Renal transplantation in older patients on peritoneal dialysis.
    Cardella CJ; Harding ME; Abraham G; Robinson C; Oreopoulos D; Uldall PR; Jordan M; Cook G; Struthers N; Honey R
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2022-3. PubMed ID: 2652660
    [No Abstract]   [Full Text] [Related]  

  • 29. Improved results of renal transplantation in diabetic nephropathy.
    Wilczek H; Gunnarsson R; Lundgren G; Ost L
    Transplant Proc; 1984 Jun; 16(3):623-7. PubMed ID: 6375029
    [No Abstract]   [Full Text] [Related]  

  • 30. Two-year results of a prospective randomized comparison of cyclosporine/low dose steroid immunosuppression with azathioprine and steroids in renal transplantation.
    Mieny CJ; Nel PJ; Becker JH; Pretorius JP
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1852. PubMed ID: 3079049
    [No Abstract]   [Full Text] [Related]  

  • 31. Stopping prednisone in kidney transplant recipients taking cyclosporine: safety conditions.
    Lloveras J; Masramon J; Orfila A; Cuevas X; Aubia J
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2027-8. PubMed ID: 2978888
    [No Abstract]   [Full Text] [Related]  

  • 32. Reduction of nephrotoxicity and improvement of immunosuppression by combination of cyclosporine A and azathioprine.
    Schareck WD; Hopt UT; Müller GH; Greger B; Risler T; Bockhorn H
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1937-9. PubMed ID: 3547898
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of 10-day and 21-day ATG-antirejection treatment in renal transplant patients treated with either cyclosporine or azathioprine as basic immunosuppression.
    Hoitsma AJ; Tiggeler RG; Wetzels JF; Berden JH; Koene RA
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1732-3. PubMed ID: 2652566
    [No Abstract]   [Full Text] [Related]  

  • 34. Does acute tubular necrosis affect renal transplant outcome? The impact of rejection episodes.
    Troppmann C; Almond PS; Payne WD; Dunn DL; Gores PF; Gruessner RW; Sutherland DE; Matas AJ; Najarian JS
    Transplant Proc; 1993 Feb; 25(1 Pt 2):905. PubMed ID: 8442263
    [No Abstract]   [Full Text] [Related]  

  • 35. A comparison of renal biopsies in cyclosporine and conventionally immunosuppressed renal transplant recipients.
    Simonton SC; Sibley RK; Fryd DS
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1790. PubMed ID: 3079038
    [No Abstract]   [Full Text] [Related]  

  • 36. Minnesota experience with 81 pancreas transplants since 1978.
    Sutherland DE; Chinn PL; Goetz FC; Elick BA; Najarian JS
    Transplant Proc; 1984 Jun; 16(3):695-703. PubMed ID: 6375036
    [No Abstract]   [Full Text] [Related]  

  • 37. Conversion of cyclosporine to azathioprine in renal transplant patients.
    Shen SY; Zemel SM; Weir MR; Dagher FJ; Bentley FR
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2032-6. PubMed ID: 3547906
    [No Abstract]   [Full Text] [Related]  

  • 38. Quality of life on cyclosporine versus conventional therapy.
    Simmons RG; Abress LK
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1860-1. PubMed ID: 3079053
    [No Abstract]   [Full Text] [Related]  

  • 39. Monotherapy with cyclosporine in kidney transplantation.
    Andreu J; Campistol JM; Oppenheimer F; Ricart MJ; Vilardell J; Carretero P
    Transplant Proc; 1990 Oct; 22(5):2270-1. PubMed ID: 2219364
    [No Abstract]   [Full Text] [Related]  

  • 40. Quadruple drug induction treatment in patients with ATN-kidneys: expensive but effective.
    Schilling M; Schleibner S; Abendroth D; Illner WD; Schneeberger H; Land W
    Transplant Proc; 1990 Oct; 22(5):2283. PubMed ID: 2219369
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.